Stay updated on Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study record page now shows a 403 Forbidden error instead of the expected trial content, with a Home link shown in the header/footer indicating the content is temporarily unavailable.SummaryDifference19%

- Check24 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, reflecting a new version of the page used for display and tracking. No study content, eligibility criteria, or results were altered.SummaryDifference0.1%

- Check38 days agoChange DetectedThe revision tag on the page was updated from v3.6.5 to v3.6.6, indicating a newer version of the document. This reflects an update to the page's revision metadata rather than changes to study details.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision tag on the page updated from v3.6.4 to v3.6.5, indicating a minor internal update to the page template/version rather than a change to study details or content.SummaryDifference0.1%

- Check67 days agoChange DetectedRecent updates to the Study Record Dates include a new last update on 2026-08-03 and related QC/submission dates (2026-07-30, 2026-07), while older 2023 timestamps were removed, indicating updated record-keeping for the study's status.SummaryDifference0.2%

Stay in the know with updates to Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.